Sebastien Quesney

Sebastien Quesney has extensive experience in various roles within the biotechnology and diagnostic industries. Sebastien currently serves as the Chief Technology Officer at NG BIOTECH since 2022. Prior to this, they worked at Institut Pasteur from 2019 to 2022, where they held the positions of Deputy Director of the innovative diagnostic test and development core facility and Head of Diagnostic Innovation Development. From 2014 to 2019, Quesney was the Director of Access to Diagnosis -Neglected Diseases- at Fondation Mérieux. Before that, they held multiple roles at IMACCESS, including General Manager and Project Executive R&D Director. Quesney also served as the R&D Director at Magnisense SE from 2007 to 2012. Sebastien began their career at bioMerieux as a Production Manager from 2002 to 2007 and worked as a Researcher at Sanofi Pasteur from 1998 to 2002.

Sebastien Quesney holds a PhD from Université Claude Bernard Lyon 1 and a DEA in Biochimie et Biologie Cellulaire from Université de Mont Saint Aignan, Rouen.